Analysis of the frequency of cardiac arrhythmias and conduction disturbances from a health-care perspective;Análisis de la frecuencia de las arritmias cardíacas y de los trastornos de conducción desde una perspectiva asistencial

Revista Espanola de Cardiologia

Volumn 58, Issue 6, 2005, Pages 657-665

  Vázquez Ruiz de Castroviejo, Eduardo ^a,b   Muñoz Bellido, Juan ^a   Lozano Cabezas, Crisotóbal ^a   Ramírez Moreno, Antonio ^a   Guzmán Herrera, Manuel ^a   Tarabini Castellani, Ada ^a   Fajardo Pineda, Antonio ^a   Jiménez Araque, Blas ^a   Armenteros Lechuga, Juan B ^a   Pagola Vilardebó, Carlos ^a  

^a Servicio de Cardiologia   (Spain)

^b NONE   (Spain)

Author keywords

Arrhythmia; Electrophysiology; Heart block

Indexed keywords

ADULT; AGED; ARTICLE; ATRIOVENTRICULAR BLOCK; FEMALE; HEART ARRHYTHMIA; HEART ATRIUM FIBRILLATION; HEART ATRIUM FLUTTER; HEART EJECTION FRACTION; HEART ELECTROPHYSIOLOGY; HEART MUSCLE CONDUCTION DISTURBANCE; HEART SUPRAVENTRICULAR ARRHYTHMIA; HEART VENTRICLE ARRHYTHMIA; HUMAN; ISCHEMIC HEART DISEASE; MAJOR CLINICAL STUDY; MALE; OUTPATIENT; PREVALENCE; QRS COMPLEX; SICK SINUS SYNDROME; TACHYCARDIA;

EID: 23044490732     PISSN: 03008932     EISSN: None     Source Type: Journal    
DOI: 10.1157/13076418     Document Type: Article

References (29)

1. Go AS, Hylek EM, Phillips KA, Chang Y, Henault LE, Selby JV, et al. Prevalence of diagnosed atrial fibrillation in adults. National implications for rhythm management and stroke prevention. The anticoagulation and risk factores in atrial fibrillation (ATRIA) study. JAMA. 2001;285:2370-5.
2. Kannel WB, Wolf PA, Benjamin EJ, Levy D. Prevalence, incidence, prognosis, and predisposing conditions for atrial fibrillation: population-based estimates. Am J Cardiol. 1998;82:N2-9.
3. Lloyd-Jones DM, Wang TJ, Leip EP, Larson MG, Levy D, Vasan RS, et al. Lifetime risk for development of atrial fibrillation: the Framingham Heart Study. Circulation. 2004;110:1042-6.
4. Furberg CD, Psaty BM, Manolio TA, Gardin JM, Smith VE, Rautaharju RM. Prevalence of atrial fibrillation in elderly subjects: the Cardiovascular Health Study. Am J Cardiol. 1994;74: 238-41.
5. Fuster V, Rydén LE, Asinger RW, Cannorn DS, Crijns HJ, Frye RL, et al. The ACC/AHA/ESC guidelines for the management of patients with atrial fibrillation. Eur Heart J. 2001;22:1852-923.
6. Blomstrom-Lundqvist C, Scheinman MM, Aliot EM, Alpert JS, Calkins H, Camm AJ, et al. ACC/AHA/ESC guidelines for the management of patients with supraventricular arrhythmias-executive summary. J Am Coll Cardiol. 2003;42:1493-531.
7. Gregoratos G, Abrams J, Epstein AE, Freedman RA, Hayes DL, Hlatky MA, et al. ACC/AHA/NASPE 2002 guidelines for implantation of cardiac pacemakers and antiarrhythmia devices: summary article. Circulation. 2002;106:2145-61.
8. Priori SG, Aliot E, Blomstrom-Lundqvist C, Bossaert L, Breithardt G, Brugada P, et al. Update of the guidelines on sudden cardiac death of the European Society of Cardiology. Eur Heart J. 2003;24:13-5.
9. Almendral J, Marín E, Medina O, Peinado R, Pérez-Álvarez L, Ruiz-Granel R, et al. Guía de práctica clínica de la Sociedad Española de Cardiología en arritmias cardíacas. Rev Esp Cardiol. 2001; 54:307-67.
10. Brignole M, Alboni P, Benditt D, Bergfeldt L, Blanc JJ, Bloch Thomsen PE, et al. Guidelines on management (diagnosis and treatment) of syncope. Eur Heart J. 2001;22:1256-306.
11. Oter R, De Juan J, Roldan T, Bardají A, Molinero E. Guía de práctica clínica de la Sociedad Española de Cardiología en marcapasos. Rev Esp Cardiol. 2000;53:947-66.
12. Shen AY, Wang X, Doris J, Moore N. Proportion of patients in a congestive heart failure care management program meeting criteria for cardiac resynchronization therapy. Am J Cardiol. 2004;94: 673-6.
13. Ezekowitz MD. Atrial fibrillation: the epidemic of the new millennium. Ann Intern Med. 1999;131:537-8.
14. Levy S, Maarek M, Coumel P, Guize L, Lekieffre J, Medvedowsky JL, et al. Characterization of different subsets of atrial fibrillation in general practice in France: the ALFA study. The College of French Cardiologists. Circulation. 1999;99:3028-35.
15. Vázquez E, Márquez A, Fajardo A, Lozano C, Guzmán M, Ramírez A, et al. Patrones clínicos de presentación de la fibrilación auricular en los pacientes hospitalizados. Rev Esp Cardiol. 2003;56: 1187-94.
16. Blanch P, Freixa R, Ibernón M, Delso J, Salas E, Sobrepera JL, et al. Utilización de anticoagulantes orales en pacientes con fibrilación auricular al alta hospitalaria en el año 2000. Rev Esp Cardiol. 2003;56:1057-63.
17. Ruiz-Ortiz M, Romo E, Franco M, Mesa D, Anguita M, López-Granados A, et al. Un protocolo prospectivo permite incrementar la utilización de anticoagulación oral en pacientes con fibrilación auricular crónica no valvular. Rev Esp Cardiol. 2003;56:971-7.
18. Vázquez E, Martín Rubio A, Pousibet H, Lozano C, Guzmán M, Tarabini A, et al. Utilización del tratamiento anticoagulante en los pacientes con fibrilación auricular no reumática. Rev Esp Cardiol. 2000;53:200-4.
19. Vázquez E, Martín Barranco MJ, Martín Rubio A, Fajardo A, Lozano C, Guzmán M, et al. Cambios en el perfil clínico de los pacientes anticoagulados durante la década de los noventa. Rev Esp Cardiol. 2002;55:55-60.
20. Hart RG, Pearce LA, Rothbart RM, McAnulty JH, Asinger RW, Halperin JL. Stroke with intermittent atrial fibrillation: incidence and predictors during aspirin therapy. Stroke Prevention in Atrial Fibrillation Investigators. J Am Coll Cardiol. 2000;35:183-7.
21. Van Walraven C, Hart RG, Wells GA, Petersen P, Koudstall PJ, Gullow A, et al. A clinical prediction rule to identify patients with atrial fibrillation and a low risk for stroke while taking aspirin. Arch Intern Med. 2003;163:936-43.
22. Aboaf AP, Wolf PS. Paroxysmal atrial fibrillation. A common but neglected entity. Arch Intern Med. 1996;156:362-7.
23. Halligan SC, Gersh BJ, Brown RD, Rosales G, Munger TM, Shen WK, et al. The natural history of lone atrial flutter. Ann Intern Med. 2004;140:265-8.
24. Bible, LA, Yuan Z, Quan KJ, Mackall JA, Rimm AA. Risk stroke in patients with atrial flutter. Am J Cardiol. 2001;87:346-9.
25. Da Costa A, Romeyer C, Mourot S, Messier M, Cerisier A, Faure E, et al. Factors associated with early atrial fibrilliation after ablation of common atrial flutter. Eur Heart J. 2002;23:498-6.
26. Álvarez-López M, Rodríguez-Font E. Registro español de ablación con catéter. II informe oficial de la sección de electrofisiología y arritmias de la Sociedad Española de Cardiología. Rev Esp Cardiol. 2003; 56:1093-104.
27. Moss AJ, Zareba W, Hall WJ, Klein H, Wilber DJ, Cannom DS, et al. Prophylactic implantation of a defibrillator in patients with myocardial infarction and reduced ejection fraction. N Engl J Med. 2002;346:877-83.
28. Bristow MR, Saxon LA, Boehmer J, Krueger S, Kass DA, De Marco T, et al. Cardiac-resynchronization therapy with or without an implantable defibrillator in advanced chronic heart failure. N Engl J Med. 2004;350:2140-50.
29. Hernández-Madrid A, Escobar C, Blanco B, Marín I, Moya JL, Moro C. Resincronización cardíaca en la insuficiencia cardíaca: bases, métodos, indicaciones y resultados. Rev Esp Cardiol. 2004; 57:680-93.